Optical Coherence Tomography Assessment of Gender diVersity In Primary Angioplasty. The OCTAVIA Trial
OCTAVIA
1 other identifier
interventional
140
1 country
14
Brief Summary
Recent studies suggest important gender differences in the pathophysiology and prognosis of ST-segment elevation myocardial infarction (STEMI). This is the first prospective controlled study to assess gender differences in the mechanism of plaque rupture/erosion and thrombus formation in patients presenting with STEMI treated with primary angioplasty. Gender-related mechanisms of plaque rupture or erosion will be investigated using a combination of Quantitative Coronary Angiography, high resolution Optical Coherence Tomography of the culprit vessel and histopathologic analyses of thrombus aspirates of the infarct related lesion, performed by independent core laboratories, blinded to group (male or female) and clinical variables.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Jan 2011
Typical duration for phase_4
14 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2011
CompletedFirst Submitted
Initial submission to the registry
January 25, 2011
CompletedFirst Posted
Study publicly available on registry
June 21, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2013
CompletedApril 19, 2013
April 1, 2013
2 years
January 25, 2011
April 18, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Percentage of ruptured or eroded plaques at infarct related lesion as assessed by OCT before PCI
To assess gender differences in the percentage of ruptured or eroded plaques at infarct related lesion as assessed by OCT. The OCT measurement is taken before stenting, when a TIMI flow 2-3 is detected. If baseline flow is TIMI 1, thrombus aspiration is performed before OCT.
Plaque rupture is evaluated during the index PCI procedure.
Percent of covered stent struts by OCT in infarct-related lesion at 9 months (co-primary endpoint).
To assess gender differences in the percentage of covered stent struts at infarct related lesion as assessed by OCT performed in all patients at 9 months.
Stent coverage is evaluated at 9 months by OCT performed in all patients.
Secondary Outcomes (6)
Minimal Fibrous Cap Thickness (MFCA) (µm) at infarct-related lesion as determined by OCT.
MFCA at index procedure (immediately after reestablishment of TIMI 2-3 coronary flow by PCI) and at 9 months OCT performed in all patients.
Presence and type of residual thrombus material in the culprit vessel.
Residual thrombus in the infarct related vessel is evaluated during the index procedure: immediately after reestablishment of TIMI 2-3 coronary flow during primary percutaneous coronary intervention
Number of TCFA (<65 µM) as assessed by OCT in the culprit vessel (infarct related).
Thin Fibrous Cap Atheroma is assessed during the index procedure: immediately after reestablishment of TIMI 2-3 coronary flow before stent implantationduring PCI; and at 9 months by OCT performed in all patients.
percent of malapposed-uncovered struts
9 months
percent net volume obstruction
9 months
- +1 more secondary outcomes
Study Arms (2)
Female Arm
EXPERIMENTALFemale gender diagnosed with ST segment Elevation Myocardial Infarction (STEMI)
Male Arm
ACTIVE COMPARATORMale Gender diagnosed with ST segment Elevation Acute Myocardial Infarction (STEMI)
Interventions
Thrombus aspiration and hystopathological analysis, Optical Coherence Tomography assessment of STEMI culprit vessel, Primary PCI with Drug Eluting Stent implantation; Repeat OCT assessment of culprit vessel at 9 monts follow-up
Eligibility Criteria
You may qualify if:
- Acute Myocardial MI with ST segment Elevation, within 6 hours from symptoms onset
- Native coronary artery disease (no prior stent implant, no prior brachytherapy)
- Signed patient informed consent
You may not qualify if:
- Patients with left main disease
- infarct lesions in bypass grafts
- cardiogenic shock
- renal failure
- recent major bleeding
- allergy to aspirin or clopidogrel
- on anticoagulant therapy
- no suitable anatomy for OCT (extreme tortuousity, very distal culprit lesion, and large infarct vessel \> 4 mm in diameter)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Italian Society of Invasive Cardiologylead
- Meditrial SrLcollaborator
Study Sites (14)
Ospedale Cardinal Massai
Asti, AT, 14100, Italy
Ospedali Riuniti di Bergamo
Bergamo, BG, 24124, Italy
Policlinico S.Orsola- Malpighi
Bologna, BO, Italy
Ospedale Ferrarotto
Catania, CT, Italy
Ospedale S. Anna
Ferrara, FE, 44100, Italy
USL 9 Grosseto
Grosseto, GR, 48100, Italy
Policlinico Gemelli
Rome, Italy, 00168, Italy
Policlinico Padova
Padua, PD, Italy
Policlinico Parma
Parma, PR, 43126, Italy
Policlinico Le Scotte
Siena, SI, 53100, Italy
Ospedale San Giovanni Bosco
Torino, TO, 10154, Italy
Ospedale Le Molinette
Torino, TO, Italy
Ospedale Mauriziano
Torino, TO, Italy
Ospedale Civile
Mirano, VE, Italy
Related Publications (2)
Saia F, Komukai K, Capodanno D, Sirbu V, Musumeci G, Boccuzzi G, Tarantini G, Fineschi M, Tumminello G, Bernelli C, Niccoli G, Coccato M, Bordoni B, Bezerra H, Biondi-Zoccai G, Virmani R, Guagliumi G; OCTAVIA Investigators. Eroded Versus Ruptured Plaques at the Culprit Site of STEMI: In Vivo Pathophysiological Features and Response to Primary PCI. JACC Cardiovasc Imaging. 2015 May;8(5):566-575. doi: 10.1016/j.jcmg.2015.01.018. Epub 2015 Apr 15.
PMID: 25890582DERIVEDGuagliumi G, Capodanno D, Saia F, Musumeci G, Tarantini G, Garbo R, Tumminello G, Sirbu V, Coccato M, Fineschi M, Trani C, De Benedictis M, Limbruno U, De Luca L, Niccoli G, Bezerra H, Ladich E, Costa M, Biondi Zoccai G, Virmani R; OCTAVIA Trial Investigators. Mechanisms of atherothrombosis and vascular response to primary percutaneous coronary intervention in women versus men with acute myocardial infarction: results of the OCTAVIA study. JACC Cardiovasc Interv. 2014 Sep;7(9):958-68. doi: 10.1016/j.jcin.2014.05.011. Epub 2014 Aug 13.
PMID: 25129664DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Giulio Guagliumi, MD
Italian Society of Invasive Cardiology
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 25, 2011
First Posted
June 21, 2011
Study Start
January 1, 2011
Primary Completion
January 1, 2013
Study Completion
April 1, 2013
Last Updated
April 19, 2013
Record last verified: 2013-04